Search : U.S. Supreme Court : Drugs & Biotech : From 10/01/04 To 07/01/05
Number of summaries found: 1
Search For More Summaries
| Court: | U.S. Supreme Court |
| Topic: | Drugs & Biotech, Intellectual Property, Patent |
| Title: | Merck v. Integra Lifesciences |
| Date: | 06/13/05 |
| Case Number: | 03-1237 |
| Summary: | The use of patented compounds in preclinical studies is protected under 37 U.S.C. section 271(e)(1) as long as there is a reasonable basis to believe that the compound tested could be the subject of an FDA submission and the experiments will produce the types of information relevant to a new drug application. |